Hospice Funding

Gareth Snell Excerpts

Thursday 19th December 2024 Commons Chamber

[Karin Smyth]

I thank the hon. Gentleman for welcoming the announcement. As I said, we will be working with the sector in the new year and then we will make allocations accordingly.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

Stoke-on-Trent is wonderfully served by the Dougie Mac and Donna Louise hospices. They are part of a healthcare system in Staffordshire and Stoke-on-Trent that the Minister knows has a £90 million projected deficit. What oversight will there be to ensure that the money that goes to the ICBs reaches the hospices and that the team in Staffordshire and Stoke-on-Trent do not try to use some of this welcome new money to fill holes elsewhere?

[Karin Smyth]

My hon. Friend makes an excellent point —one that was raised earlier. It is vital that ICBs work with all providers to understand the needs and how they are best met. I know he will be diligent, as he already has been, in pursuing what is happening with the funding with his local ICB. We will work with Hospice UK to ensure that that happens across the piece.

Oral Answers to Questions

Gareth Snell Excerpts

Tuesday 15th October 2024 Commons Chamber

[Wes Streeting]

I absolutely take the point the hon. Gentleman is making about the importance of place-based leadership. That is why one thing we will be looking to do, as part of the 10-year plan process, is to clarify roles and responsibilities in different parts of the system to ensure that we have better strategic place-based leadership.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

T9.   The Royal Stoke hospital is leading the way when it comes to treatment for stroke patients, but as with so many illnesses, prevention is better than cure. Can the Minister set out what this Government are doing to minimise the number of people affected by these life-altering events?

[Andrew Gwynne]

I agree with my hon. Friend, which is why we have set a goal for fewer lives being lost to cardiovascular disease. We will make it easier for people to have checks in the comfort of their own homes through, for example, the digital NHS health check and the new workplace trials.

Medicines

Gareth Snell Excerpts

Monday 9th September 2024 Commons Chamber

[Karin Smyth]

I understand that there are some concerns about that issue, and we will make sure that the hon. Member receives a full answer from my hon. Friend the public health Minister.

In short, these changes will widen access to life-saving medicine. I am sure hon. Members will agree that any death from an illicit drug is tragic and preventable, so I am pleased that we are taking this step and that we have the support of the House this evening for reducing drug-related deaths. On that basis, I hope hon. Members will join me in supporting these important regulatory changes, which I commend to the House.

Question put and agreed to.

Resolved,

That the draft Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, which were laid before this House on 29 July, be approved.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

On a point of order, Madam Deputy Speaker. Last Thursday, during questions to the Leader of the House on the statement of business, I asked a question about BTecs in relation to colleges. Although it is registered in the Register of Members’ Financial Interests that I am a governor of two colleges, I failed to draw the House’s attention to that fact before asking my question. The two colleges that I am a governor of are affected by the answer, so I take this opportunity to place that on the record, and offer my unreserved apology to the House accordingly.

[Madam Deputy Speaker (Judith Cummins)]

I thank the hon. Member for his point of order and his clarification. I am sure the record will stand amended and corrected.

Business of the House (Today)

Ordered,

That at today’s sitting the Speaker shall put the Questions necessary to dispose of proceedings on the Motion in the name of Lucy Powell relating to the Modernisation Committee not later than one hour after the commencement of proceedings on the Motion for this Order; such Questions shall include the Questions on any Amendments selected by the Speaker which may then be moved; proceedings on that Motion may continue, though opposed, after the moment of interruption; and Standing Order No. 41A (Deferred divisions) shall not apply.—(Lucy Powell.)

The National Health Service

Gareth Snell Excerpts

Wednesday 23rd October 2019 Commons Chamber

[Matt Hancock]

My hon. Friend is right that the local NHS came forward with its plans, but I want to ensure that A&E facilities continue in Telford. We are working on the details, and he will be the first to know.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

When the Secretary of State goes to Telford, I suggest that he speaks to Councillor Shaun Davies, who will also tell him about Telford’s needs. As the hon. Member for Burton (Andrew Griffiths) said, Staffordshire is blessed with some first-class facilities that were supported by the last Labour Government, but our problem is that our CCGs are all in financial deficit. Half of the country’s failing CCGs are in Staffordshire. With the new money that is going into the health service, will the Secretary of State tell me what he is going to do to address the disparity in funding? Stoke-on-Trent rates 13th for social and health inequalities, but 48th for funding. If money follows need, we can dig ourselves out of our hole.

[Matt Hancock]

The hon. Gentleman raises the problem across Staffordshire. We are trying to ensure that the NHS in Staffordshire looks forward with confidence, and that includes addressing long-standing financial issues for which it has had extra support over the past few years. I pay tribute to all the NHS staff right across Staffordshire, who have done great work, especially in Stoke and Stafford, to ensure that the hospital provision there can look forward with confidence.

Oral Answers to Questions

Gareth Snell Excerpts

Tuesday 18th June 2019 Commons Chamber

[Matt Hancock]

My hon. Friend makes an important point. This is a vital post in a hospital and a hospital trust that does amazing work—some of the best medicine in the world is done at King’s—but it also has significant challenges with delivery, especially with respect to meeting financial targets and delivering value for money. King’s needs that support, which we are putting in place. I will raise the specific issue of the post he mentions with the head of NHS Improvement.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

The Royal Stoke University Hospital, in partnership with Staffordshire University and Keele University, is training the next generation of clinicians, but the Secretary of State will know those universities need to be properly resourced to continue that vital training. What conversations is he having with the Department for Education to make sure that partnership thrives?

[Matt Hancock]

The hon. Gentleman raises an important point. We have expanded the number of medical training places; we have more people going into medicine; and we have a record number of GPs in training. This takes time, of course. I spoke to my right hon. Friend the Secretary of State for Education about this recently, and I will make sure that we keep pushing hard.

Oral Answers to Questions

Gareth Snell Excerpts

Tuesday 26th March 2019 Commons Chamber

[Matt Hancock]

Absolutely. My hon. Friend is right to stress the role of families in supporting the children of alcoholics. We made progress on that and were able to announce funding just last week. I pay tribute to my hon. Friend the Member for Winchester (Steve Brine) for all his work—I enjoyed doing it with him—to do everything we can to support the children of alcoholics.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

T10. Stoke-on-Trent ranks 13th in the health deprivation index, yet our funding ranks only 46th. Will the Secretary of State explain that? At what point will funding follow need?

[Matt Hancock]

The relative funding across the country for different areas is assessed independently, and by law NHS England makes that assessment. I am happy to write to the hon. Gentleman with the precise details of how those allocations are devised—I am sure that he has got them; they are widely available—and an explanation of the conclusion that NHS England independently reached.

Exiting the European Union (Food and Agriculture)

Gareth Snell Excerpts

Tuesday 19th March 2019 Commons Chamber

[Steve Brine]

The instruments, which all concern food and feed safety, relate to those substances collectively known as “regulated products” and to animal feed hygiene and marketing. They are made under the powers in the European Union (Withdrawal) Act 2018 to carry out necessary amendments to the overarching food regulations so that those can continue to protect public health from risks that may arise in connection with the consumption of food. These are protections that our constituents would expect us to pass.

As the UK leaves the European Union, the Government remain committed to maintaining the high standards of food and feed safety and consumer protection that we enjoy in this country. As some hon. Members are aware, I have recently presented numerous instruments that will help to deliver a functioning body of food and feed law. I say “some hon. Members” because, by and large, they have been taken upstairs—so I like to think that today is a bit like me moving from BBC2 to the primetime slot on BBC1. The instruments will correct deficiencies in the regulations to ensure that the UK is prepared in the event we leave the EU without an agreement.

As with all the previous statutory instruments I have presented, I wish to make it clear that these instruments make no policy changes and that it is not our intention to make any at the present time. Similarly, they are crucial to maintaining the effective controls and standards that protect public health and consumer interests in relation to regulated products used in and on food and animal feed.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

As the Minister knows, in the ceramics industry contact with food is a huge part of the regulations. What assurances can he give to me that I can relay to the industry that should Europe change its own arrangements for contact rates and provisions—in other words, if our regulatory systems diverge—producers in this country that are in line with our regulations could still sell to the EU?

--- Later in debate ---

[Steve Brine]

We have heard a number of well-made points, to which I am pleased to respond.

My dear friend opposite, the hon. Member for Washington and Sunderland West (Mrs Hodgson), often makes the point that it is late in the day. It is late in the day, but we did not say that all the SIs would be done a year ago. These are complex matters and we have to get them right. Whether they are taken now or next Tuesday is immaterial. The fact is that they will be done, as long as the House agrees to them today. It is important that they are done, because we need to make sure that the law is in the right state, as I set out in my remarks.

The hon. Lady asked about risk assessments, risk management and the loss of EFSA and its scientific expertise. Leaving the EU does not change the FSA’s top priority, which is rightly to ensure that food remains safe. The FSA has strengthened its risk-analysis process in preparation for EU exit. It has had significant extra funding this year of £14 million. That point has been raised by other hon. Members in respect of the FSA’s capabilities.

The FSA will undertake robust risk assessments and provide evidence-based risk management advice and recommendations on future food and feed safety issues. That is nothing new. The UK already produces independent risk assessments that are recognised internationally. The FSA currently undertakes a significant amount of the risk assessment and management work to maintain the high standards we expect.

The point about chlorine-washed chicken came up again, although the hon. Member for Coventry South (Mr Cunningham) is no longer in his place. I have been clear about that point many, many times. Chlorine has not been approved and so cannot be used. Chicken that is washed with chlorine cannot be placed on the UK market. The Prime Minister, the Secretary of State for Environment, Food and Rural Affairs and I have been very clear about that.

The lav—I nearly did it again! I meant to say the laboratory capability. Edit the record. The hon. Member for Washington and Sunderland West made a very good point about having the laboratory capability to assess and validate the methods of detection with the same rigour that we have had at EU level. The bottom line is that the UK is developing alternative approaches to deliver the necessary functions that are currently provided by EFSA, the European Commission and other institutions, including the EU reference laboratory.

We will build on our capacity and capability to carry out those risk assessments and then to manage and control the food and feed safety risks. We already have the network of national reference laboratories in place that help to ensure the safety of our food and feed, and to prevent the entry and spread of infectious diseases in crops, livestock and feed. They are recognised internationally for their scientific expertise, and we are working with them to ensure that they are able to validate new analytical methods and ensure that they can mirror the scientific capability that we have.

The hon. Member for Washington and Sunderland West asked about novel foods. I am touched that she thinks that is the most interesting of the four SIs—it is a low bar, but I take her point. She asked whether the UK will maintain the existing process or conduct our own review and assessment. We will start from the list as it stands on exit day. As I said to other Members, there will be full convergence at exit day. Any applications will then be assessed by our UK risk assessors. To answer her question directly, the UK advisory committee on novel foods is the body that will perform the role. That body existed prior to 2015, when that was transferred as a Commission competence. It will be unfrozen and will again carry out assessments for the novel list.

On materials and articles that are in contact with food, the hon. Lady made a point about recycling. She was referring to the requirements of Commission regulation 10/2011. That will be maintained, as I said in my opening remarks. The FSA works very closely with DEFRA, but the recycling remit lies with the Department and is not in scope of the amendments we are discussing today.

The hon. Member for Stroud (Dr Drew) is no longer in his place, but I will still respond to his point. He spoke about a food strategy to deal with the crossover between the Department of Health and Social Care and DEFRA. That point was also mentioned by my hon. Friend the Member for Camborne and Redruth (George Eustice). I am the sponsor of the FSA as an arm’s length body. It works very closely with DEFRA, the Department of Health and Social Care and Public Health England, for which I am also responsible. We continue to take a co-ordinated approach on food to support consumer choice. Yes, the fourth SI on feed could as easily have been introduced by a DEFRA Minister, but as my hon. Friend knows full well, what we give to animals ends up in the food chain, so it ends up in my brief.

The hon. Member for Washington and Sunderland West touched on consultation. She is often rightly concerned about the impact on industry, which was also mentioned by other hon. Members. We carried out a full public consultation on the proposed approach to retained EU law in the food and safety space before we tabled the SIs. It was open for six weeks from 4 September until the middle of October. The approach we outlined proposed making a number of corrections to retained EU law under the powers of the European Union (Withdrawal) Act 2018. The responses we received are all available on the food.gov.uk website. Generally speaking, of the 59 responses received, 82% supported or did not disagree in any way with the approach we proposed.

I said to the hon. Member for Stoke-on-Trent Central (Gareth Snell) that I would come back to ceramics. The ceramics legislation dates from a European directive of 1984. Why it has not been updated before now is a fair question and one that I have asked of officials. I can write to him with more detail without detaining the House. He will be interested to know that work is ongoing at a European level to revise the legislation in this space. The FSA has collaborated closely with the UK industry on the establishment of the new European limits. He may wish to follow that up and check it in his constituency, but I am sure that is the case. Obviously, we are importing the law—the directives and the directions—as they stand. Therefore, anything that was in train on exit, we would not import.

It was interesting to hear the reflections of my hon. Friend the Member for Camborne and Redruth on how the FSA grew out of the BSE crisis. We should also remember, as I have said many times, that EFSA grew out of the FSA. That is the rock on which it built its church, in many ways. The relationship between the FSA and EFSA is incredibly strong, even though the legal position will change. Many of the people there are actually our people. I am therefore confident that as the ceramics legislation changes, we will have a strong voice around the table, even if, legally, we are not around it.

[Gareth Snell]

I thank the Minister for that response. It will be heartening for some of the industries in my city, and I look forward to his letter. The issue that will be of most concern to them, albeit diminished because of his helpful answer, is that significant changes to the food contact regulations could affect the way in which they glaze their products through the use of cadmium or other elements. Whether that changes in the UK has an impact on them, but it also affects them if we lose step with Europe and have two operating standards for exports. I appreciate that that is more of a trade question than a contact question, but the two things are very much linked.

[Steve Brine]

It is a trade question, but ultimately if we want to trade with our biggest trading partner and our neighbours in the EU, we have to maintain those standards. We would not want to do anything to hobble our world famous potteries industry. I know that he agrees with that sentiment.

A lot has been said about GM food and feed. My hon. Friend the Member for Taunton Deane (Rebecca Pow) made that the kernel of her remarks. The laws around genetic modification were very high profile, perhaps due to Prince Charles’s interventions, back when I was at school.

Community Hospitals

Gareth Snell Excerpts

Tuesday 12th March 2019 Commons Chamber

[Fiona Bruce]

The hon. Gentleman is right, as he so often is. Where they are properly resourced, minor injuries units can help relieve A&E facilities and enable them to treat more serious injuries more efficiently.

More broadly, the wide range of local healthcare services at Congleton Hospital includes a 28-bed in-patient intermediate care ward called the Aston unit, which is particularly appreciated by local families visiting patients. As the hospital’s website states, that unit helps those who no longer need the more acute wards of Macclesfield District General Hospital, relieves services there and allows people to

“recover in a homely and relaxed environment”

in Congleton. The website adds that the hospital

“has a very ‘family’ feel about it.”

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

The hon. Lady is making a wonderful point about the value of community hospitals. In north Staffordshire, Bradwell Hospital, Haywood Hospital and Leek Hospital all provide excellent care, but my clinical commissioning group is consulting on closing those hospitals and reducing bed spaces. Does she agree that closing community hospitals is detrimental to the overall impact of our health economy? Exactly as she says, such hospitals free up more expensive acute beds in the big hospitals and allow people who are medically fit for discharge but are not ready to go home to get the care they need.

[Fiona Bruce]

I am sure the Minister will have heard what the hon. Gentleman has said. Indeed, that is why I entitled the debate “Community Hospitals” rather than simply “Congleton Community Hospital”.

As I have said, the hospital at Congleton has a family feel. I can testify to that following my most recent visit, just last week. I met kindly nursing staff who were clearly dedicated and committed to serving the community in and around Congleton, and who were proud to tell me that they had, through sound management, recently achieved an increase in the number of in-patients treated. About 350 are currently cared for each year in the Aston unit.

In addition to the minor injuries unit and in-patient care facilities, the hospital provides out-patient clinics, with approximately 9,000 out-patient attendances each year in a wide range of specialties. For instance, there are about 1,600 appointments a year for adult audiology treatment and about 1,000 for general surgery, and a similar number of gynaecology treatments. There are also about 2,000 trauma and orthopaedic appointments. Other services include blood tests, occupational therapy, a physiotherapy gym, district nursing, dementia services, and a highly popular GP out-of-hours service.

--- Later in debate ---

[Caroline Dinenage]

I am glad that my hon. Friend said that, because if he had not, I would have been forced to do so. We should all celebrate the hospital provision in Weston-super-Mare and the great work that is being done there.

We care deeply about ensuring that residents in all local areas can access excellent health and care services, both now and well into the future, and that is why the NHS is this Government’s No. 1 spending priority. The NHS budget will increase by £33.9 billion in cash terms by 2023-24, which is the single biggest cash increase in the NHS’s history. We have set out the what, and we now have to set out the how, which is why we are focusing on successfully implementing the NHS long-term plan. The NHS will develop a clear implementation framework, setting out how the long-term plan’s commitments will be delivered by local systems. This will be shared shortly, and it is being led by NHS England.

My hon. Friend asked whether some of the additional resources from the NHS funding settlement could be earmarked for community care so that valuable community resources such as Congleton Hospital can continue to deliver their vital services. I can confirm that we have prioritised investment in primary and community healthcare through the long-term plan, in which we have committed at least an extra £4.5 billion a year to primary medical and community health services. That additional money will fund expanded community multi-disciplinary teams and will help to ensure that, within five years, all parts of the country will have improved community health response services that can be delivered by flexible teams working across primary care and local hospitals, and developed to meet local needs.

[Gareth Snell]

I fear that the Minister may have been about to answer my question, so I apologise if she was. I welcome the suggestion that community care should be the focus of part of the new investment that is coming into the NHS. Where CCGs take a decision to reduce the number of community facilities in their area, what recourse will the public have to say, “The Minister said this, but your actions are different”? In places such as Stoke-on-Trent, what the Government are outlining is not what our CCG is doing.

[Caroline Dinenage]

The hon. Gentleman makes an incredibly strong point. I often stand at the Dispatch Box—usually during Adjournment debates—having listened to hon. Members talk about CCG decisions that they feel may not be in the best interests of their local area, but it is up to local areas to decide. The whole point of devolving money and decision making down to CCGs is that we trust them to be able to make the best decisions in the best interests of local communities to deliver services that best meet needs and priorities. If the hon. Gentleman feels that that is not happening and if he has had the opportunity to discuss that with his CCG, it could be a good idea to take the matter up with NHS England.

CCG funding allocations are decided by an independent committee, which advises NHS England on how to target health funding in line with a funding allocation formula. This objective method of allocation supports equal opportunity of access and reduces health inequalities. That way, the decision of where taxpayers’ money goes is decided in an independent and impartial manner.

As my hon. Friend the Member for Congleton will be aware, it is down to the CCG—in this case Eastern Cheshire CCG—to decide how it spends its allocation and to determine which services are the right ones for the local community it serves. One would hope that CCGs have the necessary clinical knowledge and local expertise to make informed decisions on how to spend taxpayers’ money. To support the long-term planning of services, NHS England has already informed all CCGs about how much funding they can expect to receive between 2019-20 and 2023-24. My hon. Friend may be interested to know that Eastern Cheshire CCG’s funding will increase from £270.2 million to £311.6 million over that period—a substantial increase. I hope that she will agree that that information gives CCGs the stability to plan appropriately and establish their services for the long term.

Oral Answers to Questions

Gareth Snell Excerpts

Tuesday 19th February 2019 Commons Chamber

[Caroline Dinenage]

I am grateful to my hon. Friend for mentioning his local hospice. We all have wonderful stories about the fantastic care delivered by hospices, particularly children’s hospices, in our local area. NHS England will match fund clinical commissioning groups that commit to increase their investment in all children’s palliative and end-of-life care services by up to £7 million a year by 2023-24. This, added to the children’s hospice grant, which is currently £11 million a year, could therefore more than double NHS support to a combined total of £25 million.

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

But the fact is that, even with those significant investments, most children’s hospices will still be reliant almost exclusively on fundraising and philanthropic donations. Does the Minister agree that, for there to be a proper footing for children’s hospices, there needs to be a much quicker move towards significant support from the state for these important facilities?

[Caroline Dinenage]

The hon. Gentleman talks about how children’s hospices, and indeed hospices, have traditionally been funded, but what we are looking at is an incredible commitment by NHS England to the value that hospices, and particularly children’s hospices, deliver not only in end-of-life and palliative care, but in respite care breaks and the immensely valuable outreach services that so many of them offer.

Mental Capacity (Amendment) Bill [Lords]

Gareth Snell Excerpts

2nd reading: House of Commons & Money resolution: House of Commons & Programme motion: House of Commons & Ways and Means resolution: House of Commons
Tuesday 18th December 2018 Commons Chamber

[Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)]

I will be brief, as I am aware that others wish to speak.

The privilege we have as a Parliament is to defend liberty, so any action we take to seek to deprive a person of their liberty should always be weighed against their best interest. I was not greatly aware of the deprivation of liberty safeguards until the Bill was tabled and I received lots of representations from constituents who work in the social work sector. They are concerned that, although the Bill may be well meaning, it does not necessarily have at its heart protections for the best interests of the people to whom it might apply. I have always listened when a doctor tells me something is not right and I am unwell, and we should listen when a social worker tells us that the Bill’s provisions for depriving a person of their liberty fall short of their expectations.

My hon. Friend the Member for Worsley and Eccles South (Barbara Keeley) made two excellent points. First, if we are to take away a person’s liberty, there has to be no possibility that the process could be abused for whatever purpose. I fear that, in some of the arrangements for moving away from a local authority-based system to a responsible body, the potential exists, however small that potential may be, for an unscrupulous person who is not necessarily working in the best interest of an individual to exercise that power simply to maintain a business model in their own facility or care home. Such cases may be few and far between, but we have seen many situations across the country where one or two individuals have taken advantage of people in vulnerable situations, and I am not convinced that the Bill, as currently written, goes far enough to provide safeguards. [Interruption.] The Minister shakes her head, and it would be wonderful if she could address that in her summing up.

[Mr Kevan Jones]

Will my hon. Friend give way?

[Gareth Snell]

I am sorry, but I cannot give way.

My other area of concern is the independence of advocates. I am fortunate to have a family who can speak up if a relative were ever in such a situation, but there are countless people across the country who do not have somebody who can stand up for their best interest and represent what might be right for them. The Bill contains no provision properly to strengthen the independent advocacy rights and make them robust so that everybody who might be subject to the liberty protection safeguards is able to be represented and have their views considered, which is important. [Interruption.] The Minister is nodding, and I would welcome it if she offered some sort of guidance and further clarity on how the Bill will deliver that. From where I sit, from what I have read and from the evidence given to me by social workers, there are several holes in the Bill that do not stand up to scrutiny.

I suspect the Bill will get its Second Reading, and I hope several of those holes will be identified and considered in Committee. At the moment, my fear is that the Bill is well intentioned but simply does not bear scrutiny. There is therefore a potential for exploitative people to take advantage of vulnerable people and, as a Parliament, we must make sure to address that.